Search Results 221-230 of 17378 for Proto-oncogene
Scottsdale/Phoenix, Ariz., Jacksonville, Fla. The purpose of this study is to develop a biorepository of blood samples from cancer patients participating in the ...
The purpose of this study is to compare the effectiveness of rituximab to mosunetuzumab in treating patients with follicular lymphoma with a low tumor burden.
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products ...
Oncogene. 2013; doi:10.1038/onc.2012.628. Ingle JN, et al. Estrogens and their precursors in postmenopausal women with early breast cancer receiving ...
Bevacizumab may also stop the growth of breast cancer by blocking blood flow to the tumor. Giving chemotherapy after surgery may kill any tumor cells that ...
Learn about these tumors that form from reproductive cells. Explore treatment options, including surgery, chemotherapy and radiation therapy.
About this study. The purpose of this stduy is to develop early cancer detection markers in these high risk genetically predisposed populations we require ...
Research. Mayo Clinic doctors and scientists are dedicated to improving the care of people with pancreatic cancer. Researchers in Mayo Clinic's ...
However, the presence of oncogenic signaling (Kras mutations, EGF-R) can push these duct cells to develop lesions that are at risk for tumor development. To ...
Pazopanib hydrochloride may also stop the growth of kidney cancer by blocking blood flow to the tumor. Participation eligibility. Participant eligibility ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.